{
    "organizations": [],
    "uuid": "34e12cc1ceeef80b3cf58cd9a3a72dff73bb0eae",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-weedmd-inc-submitted-application-t/brief-weedmd-inc-submitted-application-to-obtain-health-canada-dealers-license-idUSFWN1QJ0TD",
    "ord_in_thread": 0,
    "title": "Weedmd Inc - Submitted Application To Obtain Health Canada Dealer's License",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1 (Reuters) - Weedmd Inc:\n* WEEDMD INC - SUBMITTED APPLICATION TO OBTAIN HEALTH CANADA DEALER’S LICENSE UNDER CONTROLLED DRUGS & SUBSTANCES ACT & ITS ASSOCIATED REGULATIONS\n* WEEDMD INC - DEALER’S LICENSE WILL ENABLE CO TO CONDUCT RESEARCH AND DEVELOPMENT AND STORE CANNABIS DERIVATIVES Source text for Eikon: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-03-01T20:42:00.000+02:00",
    "crawled": "2018-03-02T19:47:26.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "weedmd",
        "inc",
        "weedmd",
        "inc",
        "submitted",
        "application",
        "obtain",
        "health",
        "canada",
        "dealer",
        "license",
        "controlled",
        "drug",
        "substance",
        "act",
        "associated",
        "regulation",
        "weedmd",
        "inc",
        "dealer",
        "license",
        "enable",
        "co",
        "conduct",
        "research",
        "development",
        "store",
        "cannabis",
        "derivative",
        "source",
        "text",
        "eikon"
    ]
}